May 2, 2011Date Released: 2 May 2011
CASE CCC IN THE NEWS
Comparing Cancer Care: How Can You Tell Who Has the Best?
Cleveland Clinic Researchers Link Hypertension with Improved Survival in Advanced Kidney Cancer
MARK YOUR CALENDARSCancer Center Seminar Series: MRI Contrast Agents for Imaging Tumor Microenvironment
Friday, May 6
Frohring Auditorium - BRB 105
Please join us Friday, May 6 at the next Cancer Center Seminar Series featuring Zheng-Rong Lu, PhD. Dr. Lu, Professor of Biomedical Engineering at CWRU, will present MRI Contrast Agents for Imaging Tumor Microenvironment.
Dr. Zheng-Rong Lu is the M. Frank and Margaret Domiter Rudy Professor of Biomedical Engineering at the Department of Biomedical Engineering, Case School of Engineering, Case Western Reserve University. Dr. Lu received his BS and MS in Chemistry from Lanzhou University, and PhD in Chemistry from Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences at Lanzhou, China. Dr. Lu was an Associate Professor of Chemistry in 1992 and Professor of Chemistry in 1994 at Wuhan University in China. In 2002, Dr. Lu was appointed to Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. Dr. Lu was promoted to a tenured Associate Professor in 2006.
Dr. Lu's research involves molecular imaging, MRI contrast agents, image-guided photodynamic therapy, non-invasive methods for cancer treatment assessment, polymeric drug delivery systems for retinal diseases and multifunctional delivery systems for nucleic acids. He has over 100 peer-reviewed scientific publications, five book chapters, 70 abstracts, and four US patents. He is a Principal Investigator of major grants from the NIH. Dr. Lu serves on the scientific advisory board of Pharmaceutical Research and Molecular Pharmaceutics. Currently, Dr. Lu serves as a member of the NIH Clinical Molecular Imaging and Probe Development Study Section.Case CCC Annual Scientific Retreat
The Case CCC Annual Scientific Retreat will be July 8-9 at Corporate College East. Details will be posted soon.
ANNOUNCEMENTSCourt of Appeals Stem Cell Ruling
Message from Tony Mazzaschi, Association of American Medical Colleges
In a 2-1 decision issued by a Federal Appeals Court, the preliminary injunction blocking federal funding of human embryonic stem cell research was lifted, allowing NIH funding for such research to continue. The majority said that "We conclude the plaintiffs are unlikely to prevail because Dickey-Wicker is ambiguous and the NIH seems reasonably to have concluded that, although Dickey-Wicker bars funding for the destructive act of deriving an ESC from an embryo, it does not prohibit funding a research project in which an ESC will be used. We therefore vacate the preliminary injunction." A trial on the merits of the case is still possible, as are further appeals by opponents of human embryonic stem cell research.Release of the President's Cancer Panel Report
The President's Cancer Panel is pleased to announce the release of the final report, "America's Demographic and Cultural Transformation: Implications for Cancer."
The Panel's report states that knowledge of cancer risk, incidence, progression, and outcomes is based largely on studies of non-Hispanic white populations. The current understanding of risk factors, screening guidelines, and treatment may therefore not be appropriate for individuals of non-European descent. The Panel also calls for higher standards of "cultural competence" among healthcare professionals to better address cultural and language barriers that can negatively impact the quality of patient care.
Because cancer incidence among minority populations is projected to nearly double between 2010 and 2030, the Panel calls for a more accurate assessment of the effects that a changing demographic will continue to have on cancer incidence and mortality in the coming decades.
The report includes an addendum, "How the Patient Protection and Affordable Care Act and Other Recent Legislative Activity May Impact the Panel's Recommendations." This supplement provides guidance for policymakers and the public regarding the ways in which this landmark legislation might address some of the challenges associated with providing optimal health care to an increasingly diverse population.
Hard copies of the report and the addendum may be downloaded at http://pcp.cancer.gov. Additional hard copies can be requested by contacting the Panel at email@example.com or at 301-451-9399.ASCO Annual Meeting
The Cancer Center is attempting to track members who are part of the formal program or presenting a poster at theASCO Annual Meeting, June 3-7 in Chicago. Please send information to firstname.lastname@example.org.Call for Participation- Hematopoietic Stem Cell Core Facility Survey
Message from Dr. David Wald, Scientific Director, Hematopoietic Stem Cell Core Facility
We appreciate your participation!
FUNDING OPPORTUNITIESDOD CDMRP Ovarian Cancer Research Program (OCRP)
Applications are now being accepted for the following funding opportunities from the Ovarian Cancer Research Program (OCRP):
Translational Pilot Award
Translational Leverage Award
Teal Innovator Award
The Case CCC is currently accepting applications for American Cancer Society Institutional Research Grant (IRG) awards. Pilot funding is available for projects in basic, clinical, prevention and control, behavioral, health services, and epidemiology cancer research with awards up to $30,000 for one-year cancer research projects that provide the basis for future independent grants.
Instructions, frequently asked questions, and application forms are available at http://cancer.case.edu. Contact Terri Daso, Cancer Center Administration (844-7252,email@example.com) for more information.
LOI Deadline: June 13
**All events are open to anyone interested in attending
Physiology and Biophysics Seminar
Cancer Biology Invited Speaker Seminar
Hematology and Oncology Division Research Conference
Immunology Students/Fellows Research In Progress Series
Pathology Graduate Student Seminar
NCRM and Cardiovascular Research Institute Seminar
Department of Stem Cell Biology and Regenerative Medicine Seminar
Taussig Cancer Institute Grand Rounds
Pathology Graduate Student Defense Seminar
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Breast Cancer Detection and Management: Issues for 2011
ASCO Review 2011
Case CCC Annual Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
Cincinnati Cancer Symposium Series: 2011 Symposium on NF-κB, Cancer, Obesity, and Inflammation
4th International Symposium on Cancer Metastasis and the Lymphovascular System
2nd Annual Department of Medicine Research Day
Race for the Place
International Society for Stem Cell Research (ISSCR) Annual Meeting
Cancer Health Disparities Summit 2011
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Avon Foundation Breast Cancer Research Program
DOD CDMRP Prostate Cancer Research Program Idea Development Award
NIH BULLETIN – Notices and Funding Opportunities
Center for Inherited Disease Research (CIDR) High Throughput Genotyping and Sequencing Resource Access (X01) (PAR-11-210)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.